# A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

> **NCT04587011** · PHASE1 · UNKNOWN · sponsor: **HK inno.N Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tegoprazan dose A or placebo
- **DRUG:** Tegoprazan dose B or placebo
- **DRUG:** Tegoprazan dose C or placebo
- **DRUG:** Tegoprazan dose D or placebo

## Key facts

- **NCT ID:** NCT04587011
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-24
- **Primary completion:** 2021-03
- **Final completion:** 2021-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587011, "A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT04587011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*